Pharmapark
Manufacturing · Russia · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Oktyabrskaya St 13, Krasnogorsk, Moscow ...Phone Number
+7 4956440059Website
www.pharmapark.ruRevenue
$11.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pharmapark
ФАРМАПАРК is a full-cycle biotechnology company with over 20 years of experience in the development, production, and sale of biological pharmaceuticals, particularly generics in the Russian market. The company focuses on creating safe, high-quality, and effective medications for various diseases, including cancers and chronic conditions, while actively investing in new developments and maintaining a strong R&D pipeline. With a commitment to international quality standards, ФАРМАПАРК collaborates with global partners to localize and produce innovative treatments in Russia. Their mission is to enhance the quality of life for patients by providing access to advanced biopharmaceuticals.Explore more
Pharmapark Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharmapark your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pharmapark had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Pharmapark launches new products
Congratulate Masked Content for being promoted to Masked Content at Pharmapark
Check if Pharmapark has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Pharmapark recently announced quarterly report
Pharmapark, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Pharmapark has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pharmapark is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Pharmapark is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharmapark is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharmapark.
Pharmapark Tech Stack
A closer look at the technologies used by Pharmapark
See more technologies
Pharmapark News & Media
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Bevacizumab Biosimilar in the Russian Federation
SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma and Pharmapark LLC today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma's Bevacizumab biosimilar in the Russian Federation. Prestige's Bevacizumab (HD204) is a mAb biosimilar to Roche’s Avastin®, an inhibitor of vascular endothelial growth factor (VEGF), which is used in combination with other therapies to treat patients with multiple foBio-Thera Solutions Partners with Pharmapark to Market BAT2506 in Russia and other CIS Countries
GUANGZHOU, China & MOSCOW--(BUSINESS WIRE)-- #ankylosingspondylitis--Bio-Thera Solutions Partners with Pharmapark to Market BAT2506 in Russia and other CIS Countries. BAT2506 is a proposed biosimilar of golimumab.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmapark
Sign Up For FreeTo access detailed company insights
ФАРМАПАРК is a full-cycle biotechnology company with over 20 years of experience in the development, production, and sale of biological pharmaceuticals, particularly generics in the Russian market. The company focuses on creating safe, high-quality, and effective medications for various diseases, including cancers and chronic conditions, while acti... Read More
